Navigation Links
Stabilix Publishes Version 2 of Health Companion, a Personal Healthcare Management Tool
Date:3/7/2008

SAN ANTONIO, March 7 /PRNewswire/ -- Stabilix Corporation, a software development and technology firm specializing in the healthcare marketplace, today announced that they have released a new more fully featured version of Health Companion. Stabilix Health Companion is a healthcare consumer tool that allows the individual to manage their healthcare costs, track expenses & reimbursements, and keep personal health records. The much anticipated version 2.0 is available for download at the Stabilix website now.

Stabilix Health Companion aggregates data from a variety of sources to provide a unified management tool for consumers. This product is consumer-owned - both the software and the data will remain on the individual's personal computer - while providing capability to integrate information from providers, insurance companies and health savings accounts. When consumers change jobs, healthcare insurance companies or providers, the product and information remain intact with the consumer.

"We believe that this version of the software will move consumers one step closer to acquiring the complete toolset necessary to manage and optimize the healthcare resources available to them," said George Samuel, Stabilix's Chief Executive Officer. "We are confident that the many who use the software today will find the upgraded version even richer in features and functionalities with increased ease of use. And if you are not a user of Health Companion, we encourage you to download a free evaluation copy and find out how the software can meet your individual and family needs."

Pricing and Availability

Health Companion is available both for Windows and Mac with this release. A 30-day evaluation copy of the tool can be downloaded free of cost at http://hc.stabilix.com

Consumers may also obtain a perpetual license of the product for $39.00.

About Stabilix Corporation

Stabilix Corporation is a full-service, stand-alone, advanced technology development group. It offers software products and development services targeted towards insurance companies, managed care organizations, integrated delivery networks and large physician group practices. Stabilix's core expertise is in the development and implementation of high-quality, cost-effective software solutions and technology outsourcing services. More information can be found at http://www.stabilix.com

For information, contact:

George Samuel

830.438.5760

press@stabilix.com

http://hc.stabilix.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Stabilix Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
2. American College of Physicians publishes The Fenway Guide to LGBT Health
3. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
4. Multiple Sclerosis Association of America Publishes Booklet about Depression in Multiple Sclerosis
5. American College of Physicians publishes "Peripheral Arterial Disease"
6. Thomson Scientific Publishes Who Is Making The Biggest Splash? - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007
7. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
8. The Endocrine Society Publishes White Paper Calling for Greater Minority Participation in Clinical Research
9. Springer publishes La Chirurgia degli Organi de Movimento
10. The Diabetes Educator publishes systematic reviews for diabetes management
11. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known for ... people know that popular cosmetic fillers can enhance earlobes and rejuvenate ... director of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. ...
(Date:1/18/2017)... ... 2017 , ... Delaware farmer Rick Dickerson attended the 2017 Soybean Leadership ... farms about a thousand acres of soybeans, corn and wheat, and raises peas, sweet ... other vegetables for the fresh market. He also operates a roadside stand and raises ...
(Date:1/18/2017)... ... January 18, 2017 , ... Visually ... number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive sweating and hyperhidrosis are ... Dri created this infographic to explain the seven types of hyperhidrosis. This visual ...
(Date:1/18/2017)... ANN ARBOR, Mich. USA; SAN JOSE, Calif, USA; and SHANGHAI, ... ... (PRWEB) January 18, 2017 -- Global public ... pitcher to reduce arsenic V (pentavalent arsenic) to NSF/ANSI 53: ... Standard for drinking water treatment units. This certification verifies that ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced today ... compete in the Boston Marathon on April 17. From first-time participants to accomplished ... to join Team V and support the Foundation’s mission to declare victory over cancer. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Shire plc (LSE: SHP, NASDAQ: ... and Drug Administration (FDA) has acknowledged receipt of the ... for SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. ... for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to ... the designated Prescription Drug User Fee Act (PDUFA) action ...
(Date:1/19/2017)... FRANCISCO , January 19, 2017 The global  pacemaker ... new report by Grand View Research, Inc. The heightening prevalence of cardiac conditions ... the growth of Pacemaker globally. In addition, technological enhancements in these devices are ... ... Grand View Research Logo ...
(Date:1/19/2017)... , Jan. 18, 2017   Synthetic Biologics, ... company developing therapeutics designed to preserve the microbiome ... today confirmed plans to initiate a Phase 2b/3 ... reformulation of lovastatin lactone designed to reduce methane ... in the gut to treat the underlying cause ...
Breaking Medicine Technology: